Health
First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease – UC San Diego Health
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into…
Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
The protein, called brain-derived neurotrophic factor or BDNF, is part of a family of growth factors found in the brain and central nervous system that support…
-
General20 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General17 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News21 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General5 hours agoByford rail extension opening marks final stage of Perth Metronet